Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
11/14/1989 | CA1262912A1 Tetrahydrofuranyl substituted prostaglandin analogs |
11/08/1989 | EP0341213A2 5-Aryl-substituted-2,3-dihydro-imidazo [1,2-a]furo[3,2-c]- or thieno[2,3-c]pyridines |
11/08/1989 | EP0341081A2 Novel amino acid derivatives |
11/08/1989 | EP0341006A2 Smooth muscle cell growth inhibitor |
11/08/1989 | EP0340837A1 Recombinant GAG precursor of HIV, product, process, and use as aids vaccine |
11/08/1989 | EP0340270A1 5-ht 3? receptor antagonists for treatment of cough and bronchoconstriction |
11/07/1989 | US4879374 Genetic vectors, genetic engineering |
11/07/1989 | US4879296 Xanthine derivatives |
11/07/1989 | US4879275 Penetration enhancers for transdermal delivery of systemic agent |
11/07/1989 | CA1262726A1 Pyridine compounds, process for the preparation thereof and pharmaceutical composition containing the same |
11/02/1989 | WO1989010409A1 Bone and cartilage inductive compositions |
11/02/1989 | WO1989010370A1 New alkylphosphono- and phosphoserines, method for preparing them, and pharmaceutical substances containing them |
11/02/1989 | WO1989010363A1 Fused polycyclic compounds, compositions, methods of manufacture and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
11/02/1989 | WO1989010143A1 Certain paf antagonist antihistamine combinations and methods |
11/02/1989 | WO1989010140A1 Further improvements relating to drug delivery systems |
11/02/1989 | WO1989010065A1 Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats |
11/02/1989 | EP0340153A1 N-substituted imidazoles, process for their preparation and their use in medicaments |
11/02/1989 | EP0340105A1 Diltiazem microspheres, process for producing, and sustained pharmaceutical release compositions containing them |
11/02/1989 | EP0340030A2 Triazine derivatives |
11/02/1989 | EP0340010A2 Heterocyclic nitromethane derivatives |
11/02/1989 | EP0339978A1 Fused polycyclic compounds, compositions, methods of manufacture, and their use as PAF antagonists, antihistamines and/or antiinflammatory agents |
11/02/1989 | EP0339959A2 Lactam derivatives |
11/02/1989 | EP0339905A2 Wound healing compositions containing growth factors and retinoids |
11/02/1989 | EP0339772A1 Platinum chemotherapeutic product |
11/02/1989 | EP0339709A2 Antifungal compositions and method of controlling mycotic infections |
11/02/1989 | EP0339688A1 Hydroxyphenylthioalkylketones |
11/02/1989 | EP0339656A2 Undenatured whey protein concentrate |
11/02/1989 | EP0339496A2 Aminoguanidine derivatives |
11/02/1989 | EP0339416A1 Optionally alpha-substituted 4-(quinolin-2-yl-methoxy)phenyl acetic acids and esters |
11/02/1989 | EP0339071A1 IMIDAZO(1,2-a)(PYRIDAZINES OR PYRAZINES) FOR TREATMENT OF DISEASES RELATED TO BONE LOSS |
11/02/1989 | EP0339046A1 Leukotriene b 4? analogs. |
10/31/1989 | US4877883 Substituted pyrazoles |
10/31/1989 | US4877809 Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing them |
10/31/1989 | US4877789 Antiallergens, antiinflammatory agents; skin disorders |
10/31/1989 | US4877785 Renin inhibitors |
10/31/1989 | US4877610 Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
10/25/1989 | EP0338939A1 Histamine derivative, process for his preparation and his therapeutic application |
10/25/1989 | EP0338877A1 Selective binding compounds for 5-hydroxytryptamine 1-A-receptors and pharmaceutical compositions containing them |
10/25/1989 | EP0338782A1 Benzofuran derivatives |
10/25/1989 | EP0338595A1 Hydroxyphenylthioalkylketoalcohols |
10/25/1989 | EP0338407A1 New alkylphosphonoserines, methods for preparing them, and pharmaceutical substances containing them |
10/25/1989 | EP0338372A2 Solubilized pro-drugs |
10/25/1989 | EP0338168A1 Phosphonoalkylpurine derivatives |
10/25/1989 | EP0338066A1 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss |
10/25/1989 | EP0227826B1 Novel vitamin d analogues |
10/25/1989 | CN1036569A 5-lipoxygense inhibiting 4-(4-phenyl-1-pip-erazing 1) phenols |
10/25/1989 | CN1036568A Organic compounds and their pharmaceutical use |
10/25/1989 | CN1036566A 1,3,4,5-tetrahydrobenz (c,d) indole compounds |
10/25/1989 | CN1036565A Disubstituted pyrroles |
10/25/1989 | CN1036562A Improvements in or relating to propanaming derivatives |
10/24/1989 | US4876282 1-Phenylalkylamines as selective serotonin uptake inhibitors |
10/24/1989 | US4876271 Substituted thieno[3,2-b]thiophene-2-sulfonamides as topically active carbonic anhydrase inhibitors |
10/24/1989 | US4876266 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors |
10/24/1989 | US4876242 Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast |
10/19/1989 | WO1989009800A1 Novel transdermal penetration enhancers |
10/19/1989 | WO1989009792A1 Method for potentiating and inhibiting insulin-like growth factor activity |
10/19/1989 | WO1989009788A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
10/19/1989 | WO1989009787A2 Osteogenic devices |
10/19/1989 | WO1989009786A1 Peptide derivatives |
10/19/1989 | WO1989009775A1 N-heterocyclic propylidene-1,1-bisphosphonic acids, their production and a pharmaceutical composition |
10/19/1989 | WO1989009773A1 (d)-6-FLUORO-2,3-DIHYDRO-2',5'-DIOXO-SPIRO[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2-CARBOXAMIDE DERIVATIVES, MANUFACTURING PROCESS AND USE THEREOF |
10/19/1989 | WO1989009605A1 Bone-inducing protein |
10/19/1989 | WO1989009600A1 Method and composition for treating neurological disorders |
10/19/1989 | WO1989009596A1 Structured lipid containing dairy fat |
10/19/1989 | WO1989007939A3 Coumarins to inhibit reverse transcriptase in humans |
10/19/1989 | DE3910667A1 Peptide derivatives |
10/18/1989 | EP0337938A2 19-Norprogesterone derivatives in the treatment of osteoporosis |
10/18/1989 | EP0337929A1 N-substituted imidazoles, process for their preparation and their pharmaceutical application |
10/18/1989 | EP0337928A1 N-substituted imidazoles, process for their preparation and their pharmaceutical application |
10/18/1989 | EP0337767A1 Cyclic amides |
10/18/1989 | EP0337766A1 Hetera-aliphatic carboxamides |
10/18/1989 | EP0337765A2 Acylsulfonamide derivatives of alpha-carbocyclyltoluic acids used as leukotriene antagonists |
10/18/1989 | EP0337739A2 Use of TP-receptor antagonists to modify the action of myofibroblasts |
10/18/1989 | EP0337714A2 HIV protease inhibitors useful for the treatment of aids |
10/18/1989 | EP0337697A2 Use of a thromboxane A2 receptor antagonist for the manufacture of a medicament for treating pulmonary hypertension caused by protamine induced neutralization of hepamin |
10/18/1989 | EP0337627A2 3-Substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
10/18/1989 | EP0337549A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
10/18/1989 | EP0337413A2 Naphthopyran derivatives and use thereof |
10/18/1989 | EP0337348A2 Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity, processes for their preparation and pharmaceutical compositions containing them |
10/18/1989 | EP0337295A2 Renin-inhibiting N-heterocyclic dipeptides |
10/18/1989 | EP0337176A2 Novel benzoic acid derivatives and process for preparing the same |
10/18/1989 | EP0336976A1 Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis |
10/18/1989 | EP0173753B1 6-substituted prostaglandin e1's and process for their preparation |
10/18/1989 | CN1036332A Wound healing |
10/18/1989 | CN1036328A Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis |
10/17/1989 | US4874864 Antiplasmin, antithrombin agents |
10/17/1989 | US4874850 Pharmaceutical preparations |
10/17/1989 | US4874777 Antiasthmatics |
10/17/1989 | US4874752 Benzoquinone derivatives and production thereof |
10/17/1989 | US4874746 Mixture of transforming growth factor alpha and platelet-derived growth factor |
10/17/1989 | CA1262352A1 2-(n-substitutedguanidino)-4-hetero-arylthiazole antiulcer agents |
10/17/1989 | CA1262335A1 Hair growth modification |
10/12/1989 | EP0262178A4 Amino acid chelated compositions for delivery to specific biological tissue sites. |
10/11/1989 | EP0336880A2 Use of topical applicable preparation for treating skin aging |
10/11/1989 | EP0336760A2 Bone-inducing protein |
10/11/1989 | EP0336753A1 Improvements in or relating to propanamine derivatives |
10/11/1989 | EP0336416A1 (d)-6-Fluoro-2,3-dihydro-2',5'-dioxo-spiro[1H-1-Benzopyran-4,4'-imidazolidine]-2-carboxamide derivatives, process for the preparation and use of the derivatives |
10/11/1989 | EP0336305A1 Alpha-trifluoromethylamino acid derivatives, processes for preparing alpha-trifluoamino acid derivatives and their use as medicaments |
10/11/1989 | CN1036207A Novel aspartate transcarbamylase inhibitors |
10/11/1989 | CN1036135A Growth inhibiting agent and use thereof |